Secukinumab 150 mg/ml ( DrugBank: Secukinumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
271	Ankylosing spondylitis	1

271. Ankylosing spondylitis

Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05527444 (ClinicalTrials.gov)	March 15, 2022	6/5/2022	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	Ankylosing Spondylitis	Drug: Secukinumab 150 mg/ml;Drug: Adalimumab Ab;Drug: NSAID;Drug: Thalidomide Pill	Qilu Hospital of Shandong University	NULL	Recruiting	18 Years	65 Years	All	100	Phase 4	China

First Previous1Next Last